Author: BusinessWire

Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the…

– Conference call and webcast today at 4:30 p.m. ET – NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology…

Potential FDA approval of AR101 for peanut allergy expected by late January 2020; Company on target to be launch-ready in…

Columbia Care to partner with experts at Montefiore Medical Center and Albert Einstein College of Medicine for initial phase of…

-Company to Hold Conference Call Today at 4:30 PM ET- WATERTOWN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24TTPH&src=ctag" target="_blank"gt;$TTPHlt;/agt; lt;a href="https://twitter.com/hashtag/antibioticresistance?src=hash" target="_blank"gt;#antibioticresistancelt;/agt;–Tetraphase Pharmaceuticals, Inc.…

LAVAL, Québec–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Altasciences?src=hash" target="_blank"gt;#Altascienceslt;/agt;–Altasciences won in the Most Successful Early Phase Research (Preclinical & Phase I) category at the…

DUBLIN–(BUSINESS WIRE)–The “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors – Pipeline Insights, 2019” drug pipelines has been added to ResearchAndMarkets.com’s…

DUBLIN–(BUSINESS WIRE)–The “Klebsiella Pneumoniae Infections – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers…

DUBLIN–(BUSINESS WIRE)–The “Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Insight, 2019” drug pipelines has been added to…

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, today announced…